IARC Monographs establish their priorities for carcinogenicity evaluations

The International Agency for Research on Cancer (IARC), the cancer agency of the World Health Organization (WHO), has established their priorities for the evaluation of carcinogens.

An Advisory Group of 28 independent scientists from 22 countries, including Susan Peters from the Institute for Risk Assessment Sciences, met in Lyon to recommend priorities for carcinogenicity evaluations by the IARC. This periodic evaluation ensures that the agents evaluated in the Monographs are selected based on the latest scientific evidence relevant to carcinogenicity. The Advisory Group recommended a broad range of agents for evaluation with high, medium, or no priority.

A summary of the recommended Priorities for the IARC Monographs during 2025–2029 has now been published in The Lancet Oncology.

Amy Berrington de González, Scott A Masten, Parveen Bhatti, Renée Turzanski Fortner, Susan Peters, Tiina Santonen, et al.
Advisory Group recommendations on priorities for the IARC Monographs
Lancet Oncol, Published online April 12, 2024
https://doi.org/10.1016/S1470-2045(24)00208-0